Published in Hum Gene Ther on November 20, 2000
Consensus guidelines for the detection of immunogenic cell death. Oncoimmunology (2014) 2.30
Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol (2002) 1.74
Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma. J Clin Oncol (2011) 1.71
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin. Cancer Res (2007) 1.50
New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med (2013) 1.35
Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model. Neuro Oncol (2007) 1.31
Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur Spine J (2006) 1.25
Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J Pharm Sci (2011) 1.24
The art of gene therapy for glioma: a review of the challenging road to the bedside. J Neurol Neurosurg Psychiatry (2012) 1.24
Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression. Clin Cancer Res (2009) 1.24
Experimental approaches for the treatment of malignant gliomas. Pharmacol Ther (2010) 1.23
Progress in gene therapy for neurological disorders. Nat Rev Neurol (2013) 1.22
Glioblastoma multiforme: State of the art and future therapeutics. Surg Neurol Int (2014) 1.18
Prodrug approaches for CNS delivery. AAPS J (2008) 1.17
Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther (2008) 1.17
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy). J Biomed Biotechnol (2003) 1.11
Tissue-specific transcriptional targeting of a replication-competent retroviral vector. J Virol (2002) 1.10
Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol (2011) 1.09
Emerging insights into barriers to effective brain tumor therapeutics. Front Oncol (2014) 1.08
Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines. Neurosurg Rev (2008) 1.06
Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits. Mol Ther (2008) 1.05
Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma. PLoS One (2011) 1.05
A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clin Cancer Res (2012) 1.04
Applications of gene therapy to the treatment of chronic pain. Curr Gene Ther (2008) 1.03
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2005) 1.02
Novel delivery strategies for glioblastoma. Cancer J (2012) 1.01
Optogenetic neuronal stimulation promotes functional recovery after stroke. Proc Natl Acad Sci U S A (2014) 0.98
Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. Cancer Gene Ther (2010) 0.98
Gene therapy for brain tumors: basic developments and clinical implementation. Neurosci Lett (2012) 0.98
Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas. Curr Stem Cell Res Ther (2009) 0.98
Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo. ACS Nano (2014) 0.97
Gene therapy and targeted toxins for glioma. Curr Gene Ther (2011) 0.97
Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells Dev (2012) 0.97
Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy. PLoS One (2009) 0.96
Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo. ACS Nano (2015) 0.96
The status of gene therapy for brain tumors. Expert Opin Biol Ther (2007) 0.95
Glioma virus therapies between bench and bedside. Neuro Oncol (2014) 0.95
Sui generis: gene therapy and delivery systems for the treatment of glioblastoma. Neuro Oncol (2015) 0.94
What next for newly diagnosed glioblastoma? Future Oncol (2015) 0.94
Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis. Mol Ther (2012) 0.94
Optimizing targeted gene delivery: chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J (2006) 0.91
HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector. Nanomedicine (2010) 0.91
Polymeric drug delivery for the treatment of glioblastoma. Neuro Oncol (2015) 0.90
Cancer stem cells: the final frontier for glioma virotherapy. Stem Cell Rev (2011) 0.89
Adenoviral virotherapy for malignant brain tumors. Expert Opin Biol Ther (2009) 0.88
Gene therapy trials for the treatment of high-grade gliomas. Gene Ther Mol Biol (2007) 0.88
Suicide Gene Therapy for Cancer - Current Strategies. J Genet Syndr Gene Ther (2013) 0.87
Strategies in gene therapy for glioblastoma. Cancers (Basel) (2013) 0.87
Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene. J Neurooncol (2014) 0.87
Evolving gene therapy approaches for osteosarcoma using viral vectors: review. Bone (2006) 0.87
A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet Vaccines Ther (2004) 0.86
Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells. BMC Cancer (2005) 0.86
Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors. Front Cell Neurosci (2013) 0.86
Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles. Adv Drug Deliv Rev (2014) 0.84
Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity. DNA Repair (Amst) (2013) 0.84
Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir Res (2014) 0.83
Gene therapy for malignant glioma. Mol Cell Ther (2014) 0.83
Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene. Mol Ther (2010) 0.82
Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival. Biomaterials (2016) 0.81
The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy. Cancers (Basel) (2013) 0.81
Gene- and viral-based therapies for brain tumors. Neurotherapeutics (2009) 0.81
Molecular therapies for malignant glioma. Wien Med Wochenschr (2006) 0.81
Gene therapy for high-grade glioma: current approaches and future directions. Cell Adh Migr (2008) 0.81
A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells. Neuro Oncol (2010) 0.80
Thermoreversible poly(ethylene glycol)-g-chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy. Biomacromolecules (2014) 0.80
Cancer gene therapy clinical trials: lessons for the future. Br J Cancer (2001) 0.80
The Anti-Tumor Effects of Adipose Tissue Mesenchymal Stem Cell Transduced with HSV-Tk Gene on U-87-Driven Brain Tumor. PLoS One (2015) 0.80
Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate. J Exp Clin Cancer Res (2011) 0.79
Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders. Int Rev Neurobiol (2003) 0.79
Stem cell in alternative treatments for brain tumors: potential for gene delivery. Mol Cell Ther (2014) 0.79
Neuro-oncology: The long and winding road--gene therapy for glioma. Nat Rev Neurol (2013) 0.79
Intrathecal gene therapy for treatment of leptomeningeal carcinomatosis. J Neurooncol (2010) 0.79
Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets. Cell Mol Neurobiol (2001) 0.79
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. BMC Mol Biol (2009) 0.78
Targeted therapy in the treatment of malignant gliomas. Onco Targets Ther (2009) 0.78
Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice. Exp Ther Med (2014) 0.78
A systematic review and meta-analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy? Evid Based Preclin Med (2015) 0.78
Gene-directed enzyme prodrug therapy. AAPS J (2014) 0.77
Effective combination gene therapy using CEACAM6-shRNA and the fusion suicide gene yCDglyTK for pancreatic carcinoma in vitro. Exp Ther Med (2012) 0.77
Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther (2016) 0.77
Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation. PLoS Genet (2012) 0.77
Novel treatment strategies for malignant gliomas using neural stem cells. Neurotherapeutics (2009) 0.77
Human gene therapy and imaging in neurological diseases. Eur J Nucl Med Mol Imaging (2005) 0.77
Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas. Theranostics (2016) 0.77
Utilizing native fluorescence imaging, modeling and simulation to examine pharmacokinetics and therapeutic regimen of a novel anticancer prodrug. BMC Cancer (2016) 0.76
Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow? Gene Ther (2010) 0.76
Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice. BMC Cancer (2005) 0.76
Herpes simplex virus type 1/adeno-associated virus hybrid vectors. Open Virol J (2010) 0.75
A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme. World J Exp Med (2011) 0.75
Stem cells as cellular vehicles for gene therapy against glioblastoma. Int J Clin Exp Med (2015) 0.75
Potential new gene therapy option with sitimagene ceradenovec for newly diagnosed patients with glioblastoma multiforme. Cancer Biol Ther (2013) 0.75
Neural stem cell therapy for cancer. Methods (2015) 0.75
Maintaining therapeutic activity in the operating room: compatibility of a gamma-retroviral replicating vector with clinical materials and biofluids. Mol Ther Methods Clin Dev (2014) 0.75
Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses. Neurosurgery (2014) 0.75
Clinical development of experimental therapies for malignant glioma. Sultan Qaboos Univ Med J (2011) 0.75
Safety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines. J Cancer (2014) 0.75
Use of genetically engineered stem cells for glioma therapy. Oncol Lett (2015) 0.75
Selective expansion and enhanced anti-tumor effect of antigen-specific CD4(+) T cells by retrovirus-mediated IL-15 expression. Protein Cell (2011) 0.75
New Variants of Tomato Thymidine Kinase 1 Selected for Increased Sensitivity of E. coli KY895 towards Azidothymidine. Cancers (Basel) (2015) 0.75
Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma. Plast Reconstr Surg (2015) 0.75